(Q82837028)

English

Vedolizumab for the treatment of active ulcerative colitis: a randomized controlled phase 2 dose-ranging study

scientific article published on 06 December 2011

Statements

Vedolizumab for the treatment of active ulcerative colitis: a randomized controlled phase 2 dose-ranging study (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit